LIVE MARKET TRACKER :   BSE SENSEX   33227.99      |    NSE NIFTY 10240.15    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Videocon Industries touches roof with arm entering into eKYC business

Videocon Industries touches roof with arm entering into eKYC business (21-Jul-2017)

Videocon Industries is locked at upper circuit limit of Rs. 26.05, up by 1.20 points or 4.83% from its previous closing of Rs. 24.85 on the BSE.

The scrip opened at Rs. 24.10 and has touched a high and low of Rs. 26.05 and Rs. 23.80 respectively. So far 1246533 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 114.90 on 06-Oct-2016 and a 52 week low of Rs. 16.35 on 27-Jun-2017.

Last one week high and low of the scrip stood at Rs. 28.90 and Rs. 23.80 respectively. The current market cap of the company is Rs. 871.27 crore.

The promoters holding in the company stood at 66.04%, while Institutions and Non-Institutions held 11.54% and 10.81% respectively.

Videocon Industries' telecom arm - Videocon Telecom has entered into eKYC business for Aadhaar-linked services and set a revenue target of up to Rs 100 crore from the segment in the next two years.

The company has obtained both ASA (authentication service agencies) and AUA (authenticated user agencies) licences for the Aadhaar-based digitalization.

The company has 60 offices across the country to sell business to business solution. It will leverage workforce at these offices for expansion eKYC business.


Top News Today
Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets
(12-Dec-2017)

Alembic Pharma gets USFDAAlembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Darifenacin Extended-Release Tablets, 7.5 mg and 15......click on news to read complete article.

Bajaj Hindusthan Sugar planning to issue OCDs worth Rs 3483.25 crore
(12-Dec-2017)

Bajaj Hindusthan Sugar planning to issue OCDs worth Rs 3483.25 croreBajaj Hindusthan Sugar is planning to issue Optionally Convertible Debentures (OCDs) aggregating to Rs 3483.25 crore to the Lenders of the Company upon conversion of Part - B (Unsustainable portion) of......click on news to read complete article.

Cholamandalam Invetsment planning to issue masala bonds
(12-Dec-2017)

Cholamandalam Invetsment planning to issue masala bondsCholamandalam Investment and Finance Company is planning to issue masala bonds in the nature of non-convertible debentures on a private placement basis. The meeting of the Board of Directors of the Company......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.